Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact
Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Lanton Law Quoted in Bloomberg Law

We have been talking a lot lately about drug pricing; specifically Most Favored Nation (MFN) and other ancillary issues. We were recently quoted in Bloomberg Law News on the issue here. Thanks to Nyah Phengsitthy for reaching out.

life sciences, healthcareRon LantonNovember 25, 2025healthcare, MFN, Most-Favored-Nation (MFN) Pricing, drug pricing
0 Likes
Previous

Lanton Law Returns to Moderate Most Favored Nation Panel for Pharmacy Times

healthcare, life sciencesRon LantonNovember 25, 2025Most Favored Nation, MFN, drug pricing, healthcare, life sciences
Next

Lanton Law Moderates Most Favored Nation Panel for MJH Life Sciences

healthcare, life sciences, Medicare Part B, Most Favored Nation, pharmaceuticals, prescription drug costsRon LantonOctober 12, 2025MFN, Most-Favored-Nation (MFN) Pricing, Pfizer, Drug Price, Medicare Part B, Inflation Reduction Act, IRA, insurance, healthcare, pharmaceutical, PhRMA